{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"âœ… Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"ðŸ”‘ Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:04:57.861465Z","iopub.execute_input":"2025-11-14T04:04:57.861825Z","iopub.status.idle":"2025-11-14T04:04:57.948709Z","shell.execute_reply.started":"2025-11-14T04:04:57.861796Z","shell.execute_reply":"2025-11-14T04:04:57.947341Z"}},"outputs":[{"name":"stdout","text":"âœ… Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":1},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"âœ… ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:05:14.447539Z","iopub.execute_input":"2025-11-14T04:05:14.447922Z","iopub.status.idle":"2025-11-14T04:06:17.815336Z","shell.execute_reply.started":"2025-11-14T04:05:14.447892Z","shell.execute_reply":"2025-11-14T04:06:17.814356Z"}},"outputs":[{"name":"stdout","text":"âœ… ADK components imported successfully.\n","output_type":"stream"}],"execution_count":2},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"âœ… Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:10:43.358789Z","iopub.execute_input":"2025-11-14T04:10:43.359655Z","iopub.status.idle":"2025-11-14T04:10:43.369668Z","shell.execute_reply.started":"2025-11-14T04:10:43.359619Z","shell.execute_reply":"2025-11-14T04:10:43.368512Z"}},"outputs":[{"name":"stdout","text":"âœ… Helper functions defined.\n","output_type":"stream"}],"execution_count":3},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:11:04.158625Z","iopub.execute_input":"2025-11-14T04:11:04.159089Z","iopub.status.idle":"2025-11-14T04:11:04.165330Z","shell.execute_reply.started":"2025-11-14T04:11:04.159049Z","shell.execute_reply":"2025-11-14T04:11:04.164234Z"}},"outputs":[],"execution_count":4},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:12:48.877651Z","iopub.execute_input":"2025-11-14T04:12:48.878028Z","iopub.status.idle":"2025-11-14T04:12:48.886406Z","shell.execute_reply.started":"2025-11-14T04:12:48.878002Z","shell.execute_reply":"2025-11-14T04:12:48.885298Z"}},"outputs":[{"name":"stdout","text":"âœ… Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":5},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:13:18.827027Z","iopub.execute_input":"2025-11-14T04:13:18.827364Z","iopub.status.idle":"2025-11-14T04:13:20.400593Z","shell.execute_reply.started":"2025-11-14T04:13:18.827341Z","shell.execute_reply":"2025-11-14T04:13:20.399383Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":6},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n    \"stateful-agentic-session\",\n) ","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:14:17.414830Z","iopub.execute_input":"2025-11-14T04:14:17.415232Z","iopub.status.idle":"2025-11-14T04:14:18.511366Z","shell.execute_reply.started":"2025-11-14T04:14:17.415204Z","shell.execute_reply":"2025-11-14T04:14:18.510346Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > What did I ask you about earlier?\ngemini-2.5-flash-lite >  You asked me about the capital of the United States.\n\nUser > And remind me, what's my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":7},{"cell_type":"code","source":"chatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:15:10.894706Z","iopub.execute_input":"2025-11-14T04:15:10.895084Z","iopub.status.idle":"2025-11-14T04:15:11.034370Z","shell.execute_reply.started":"2025-11-14T04:15:10.895056Z","shell.execute_reply":"2025-11-14T04:15:11.032739Z"}},"outputs":[{"name":"stdout","text":"âœ… Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":8},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:15:37.423251Z","iopub.execute_input":"2025-11-14T04:15:37.423611Z","iopub.status.idle":"2025-11-14T04:15:38.737664Z","shell.execute_reply.started":"2025-11-14T04:15:37.423586Z","shell.execute_reply":"2025-11-14T04:15:38.736568Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":9},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:15:55.056004Z","iopub.execute_input":"2025-11-14T04:15:55.056394Z","iopub.status.idle":"2025-11-14T04:15:56.230936Z","shell.execute_reply.started":"2025-11-14T04:15:55.056369Z","shell.execute_reply":"2025-11-14T04:15:56.229785Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":10},{"cell_type":"code","source":"await run_session(\n    runner, [\"Hello! What is my name?\"], \"test-db-session-02\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:16:53.917844Z","iopub.execute_input":"2025-11-14T04:16:53.918193Z","iopub.status.idle":"2025-11-14T04:16:54.703799Z","shell.execute_reply.started":"2025-11-14T04:16:53.918165Z","shell.execute_reply":"2025-11-14T04:16:54.702576Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-02\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:17:46.798828Z","iopub.execute_input":"2025-11-14T04:17:46.799197Z","iopub.status.idle":"2025-11-14T04:17:46.807547Z","shell.execute_reply.started":"2025-11-14T04:17:46.799164Z","shell.execute_reply":"2025-11-14T04:17:46.806332Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"# Re-define our app with Events Compaction enabled\nresearch_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"âœ… Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:19:41.758677Z","iopub.execute_input":"2025-11-14T04:19:41.759066Z","iopub.status.idle":"2025-11-14T04:19:41.770320Z","shell.execute_reply.started":"2025-11-14T04:19:41.759039Z","shell.execute_reply":"2025-11-14T04:19:41.768924Z"}},"outputs":[{"name":"stdout","text":"âœ… Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:20:24.966286Z","iopub.execute_input":"2025-11-14T04:20:24.966646Z","iopub.status.idle":"2025-11-14T04:20:41.960745Z","shell.execute_reply.started":"2025-11-14T04:20:24.966619Z","shell.execute_reply":"2025-11-14T04:20:41.959815Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  The field of AI in healthcare is incredibly dynamic, with new advancements and applications emerging constantly. Here's a summary of some of the latest trends and significant news, broken down into key areas:\n\n**1. Diagnostics and Medical Imaging:**\n\n*   **Enhanced Accuracy and Speed:** AI algorithms continue to demonstrate impressive capabilities in analyzing medical images (X-rays, CT scans, MRIs, pathology slides) to detect diseases like cancer, diabetic retinopathy, and neurological conditions with accuracy often matching or exceeding human experts. The focus is on faster, more consistent diagnoses.\n*   **Early Disease Detection:** AI is becoming more sophisticated in identifying subtle patterns that might indicate early signs of disease, potentially leading to earlier interventions and better patient outcomes. This includes predicting risk factors for conditions like cardiovascular disease.\n*   **Personalized Treatment Recommendations:** Beyond just diagnosis, AI is being used to analyze patient data to suggest the most effective and personalized treatment plans based on individual characteristics and predicted responses.\n\n**2. Drug Discovery and Development:**\n\n*   **Accelerated R&D:** AI is revolutionizing drug discovery by sifting through vast datasets of biological and chemical information to identify potential drug candidates much faster than traditional methods. This includes predicting drug efficacy and potential side effects.\n*   **Repurposing Existing Drugs:** AI is helping identify existing drugs that could be effective for new diseases, significantly shortening the development timeline and reducing costs.\n*   **Clinical Trial Optimization:** AI is being used to improve patient selection for clinical trials, predict trial outcomes, and even design more efficient trial protocols.\n\n**3. Personalized Medicine and Genomics:**\n\n*   **Understanding Genetic Predispositions:** AI is crucial in analyzing complex genomic data to understand an individual's genetic predisposition to certain diseases and to tailor treatments accordingly.\n*   **Precision Oncology:** AI is playing a major role in precision oncology, helping oncologists select the most effective therapies based on a tumor's specific genetic makeup.\n\n**4. Operational Efficiency and Administration:**\n\n*   **Automating Administrative Tasks:** AI-powered tools are automating routine administrative tasks like scheduling appointments, managing patient records, and processing insurance claims, freeing up healthcare professionals for patient care.\n*   **Predictive Analytics for Resource Management:** Hospitals are using AI to predict patient flow, manage bed capacity, optimize staffing, and anticipate equipment needs, leading to more efficient operations.\n*   **Fraud Detection:** AI algorithms are being employed to identify fraudulent claims and billing practices within the healthcare system.\n\n**5. Patient Engagement and Remote Monitoring:**\n\n*   **Virtual Health Assistants:** AI-powered chatbots and virtual assistants are providing patients with information, answering common questions, and offering support for managing chronic conditions.\n*   **Remote Patient Monitoring:** AI is enhancing remote patient monitoring systems by analyzing data from wearable devices and other sensors to detect concerning trends and alert healthcare providers.\n*   **Mental Health Support:** AI is being explored for providing accessible mental health support through conversational agents and analyzing patterns in communication to identify individuals at risk.\n\n**Key Developments and Trends to Watch:**\n\n*   **Generative AI (like LLMs):** Large Language Models (LLMs) are making significant inroads, with applications in summarizing medical literature, generating clinical notes, assisting in medical writing, and even aiding in patient communication. However, ethical considerations and accuracy remain paramount.\n*   **Explainable AI (XAI):** As AI becomes more integrated into critical healthcare decisions, there's a growing demand for \"explainable AI,\" where the reasoning behind an AI's decision can be understood by clinicians.\n*   **Regulatory Landscape:** Regulatory bodies like the FDA are actively working on frameworks to evaluate and approve AI-driven medical devices and software, ensuring safety and efficacy.\n*   **Data Privacy and Security:** With vast amounts of sensitive patient data being used, robust data privacy and security measures remain a critical focus.\n*   **Ethical Considerations:** Discussions around bias in AI algorithms, equitable access to AI-powered healthcare, and the responsible deployment of AI in clinical settings are ongoing and crucial.\n\n**Where to Find Latest News:**\n\nTo stay truly up-to-date, I recommend following:\n\n*   **Reputable Medical Journals:** JAMA, The Lancet, NEJM, Nature Medicine.\n*   **Leading Technology and Healthcare News Outlets:** TechCrunch, Wired, STAT News, FierceBiotech, Healthcare Dive.\n*   **AI Research Publications and Conferences:** Major AI conferences (NeurIPS, ICML) often have healthcare-specific tracks, and academic institutions publish cutting-edge research.\n*   **Company Announcements:** Keep an eye on news from major tech companies (Google, Microsoft, IBM) and specialized health AI companies.\n\nThe pace of innovation is remarkable, and AI is poised to continue transforming healthcare in profound ways.\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, absolutely! Drug discovery is one of the areas where AI is having a particularly profound and rapid impact. There are many exciting new developments. Here are some of the key areas and recent advancements:\n\n**1. Accelerating Target Identification and Validation:**\n\n*   **Multi-omics Data Integration:** AI is becoming increasingly adept at integrating and analyzing massive, complex datasets from genomics, transcriptomics, proteomics, and metabolomics. This allows researchers to identify novel disease targets that might have been missed with traditional methods.\n*   **Predictive Modeling of Disease Pathways:** AI models can map out intricate biological pathways involved in disease and predict which targets are most likely to be druggable and have a significant therapeutic effect.\n*   **Leveraging Real-World Data (RWD):** AI is used to analyze RWD (e.g., electronic health records, insurance claims) to identify unmet needs, understand disease progression, and pinpoint patient populations that could benefit from new therapies.\n\n**2. Novel Molecule Design and Optimization:**\n\n*   **Generative AI for De Novo Design:** This is a major area of progress. Generative AI models (like GANs and VAEs, and increasingly LLMs) are capable of designing entirely new molecular structures with desired properties (e.g., high binding affinity to a target, favorable pharmacokinetic profiles). Companies are reporting success in generating novel drug candidates from scratch.\n*   **Predicting Molecule Properties:** AI can predict a vast array of properties for newly designed molecules, including solubility, toxicity, absorption, distribution, metabolism, and excretion (ADME), and even potential off-target effects, significantly reducing the need for costly and time-consuming experimental validation.\n*   **Fragment-Based Drug Design Enhancement:** AI can help optimize fragments that bind to target proteins, suggesting ways to link or grow them into more potent drug candidates.\n\n**3. Improving Pre-clinical and Clinical Trials:**\n\n*   **Biomarker Discovery:** AI can identify novel biomarkers that predict patient response to a drug, helping to stratify patient populations for clinical trials and increasing the likelihood of success.\n*   **Clinical Trial Design Optimization:** AI is being used to design more efficient clinical trials by identifying optimal patient inclusion/exclusion criteria, predicting trial duration, and even simulating trial outcomes.\n*   **Predicting Drug Efficacy and Safety:** AI models can analyze pre-clinical data to better predict how a drug might perform in human trials, potentially flagging candidates with a higher risk of failure early on.\n*   **Virtual Screening:** AI can rapidly screen massive libraries of existing compounds to identify those that are most likely to interact with a specific disease target, saving significant time and resources.\n\n**4. Repurposing Existing Drugs:**\n\n*   **Network Analysis:** AI can analyze complex biological networks and drug interaction data to identify existing drugs that might be effective against new or different diseases. This is a faster and less expensive route to new treatments.\n\n**Examples of Recent Progress:**\n\n*   **Companies like Insilico Medicine, Atomwise, and Exscientia** are frequently in the news for their AI-driven drug discovery platforms, announcing partnerships, successful pre-clinical candidates, and even drugs entering clinical trials that were discovered using AI.\n*   **Specific therapeutic areas** where AI is making strides include oncology (cancer), infectious diseases (like COVID-19, where AI helped identify existing drugs for repurposing), and neurological disorders.\n*   **AI's role in developing novel antibiotics** is also a growing area, addressing the critical challenge of antimicrobial resistance.\n\n**Challenges Remain:**\n\nDespite the immense progress, challenges persist:\n\n*   **Data Quality and Accessibility:** High-quality, curated biological and chemical data is essential for training effective AI models.\n*   **Experimental Validation:** AI predictions still require rigorous experimental validation, which can be a bottleneck.\n*   **Interpretability and Trust:** Clinicians and regulators need to trust AI-generated insights, leading to the push for explainable AI (XAI).\n*   **Regulatory Hurdles:** The regulatory framework for AI-discovered drugs is still evolving.\n\nIn summary, AI is not just speeding up drug discovery; it's fundamentally changing how new medicines are conceived, designed, and tested, promising a future with more effective and personalized treatments developed more rapidly.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're referring to the **\"Novel Molecule Design and Optimization\"** development in drug discovery. This is a particularly exciting area because AI is moving beyond just identifying existing possibilities to actually creating *new* ones.\n\nLet's dive deeper into what this entails:\n\n**The Core Idea: Generative AI for De Novo Design**\n\nTraditionally, drug discovery involved screening vast libraries of existing chemical compounds to find ones that might interact with a disease target. This is like searching for a specific key in a huge box of pre-made keys.\n\n**Generative AI flips this script.** Instead of searching, it **learns the rules of chemistry and biology** and then uses that knowledge to **design entirely new molecules from scratch** that are tailored to a specific purpose. This is like being able to design and 3D-print a brand new key that perfectly fits a specific lock.\n\n**How it Works (Simplified):**\n\n1.  **Learning the Rules:** AI models are trained on massive datasets of known molecules, their chemical properties, and their interactions with biological targets. This allows them to understand the fundamental principles of molecular structure, bonding, and how molecules behave in biological systems.\n2.  **Defining the Goal:** Researchers specify what they want the new molecule to do. This might include:\n    *   Binding strongly to a specific protein (the disease target).\n    *   Having certain solubility or stability properties.\n    *   Minimizing predicted toxicity.\n    *   Being easily synthesizable in a lab.\n3.  **Generating Candidates:** Based on the learned rules and the defined goals, the AI model generates a large number of novel molecular structures. These are often represented in simplified formats like SMILES strings.\n4.  **Filtering and Ranking:** The AI then evaluates these generated candidates based on the specified criteria, ranking them by their predicted efficacy, safety, and synthesizability.\n5.  **Iterative Refinement:** This process is often iterative. The AI can refine its designs based on feedback from the initial screening, leading to progressively better candidates.\n\n**Key Technologies and Approaches:**\n\n*   **Deep Generative Models:**\n    *   **Generative Adversarial Networks (GANs):** These models involve two neural networks â€“ a generator (which creates molecules) and a discriminator (which tries to distinguish between real and generated molecules). They learn from each other to produce increasingly realistic and effective molecules.\n    *   **Variational Autoencoders (VAEs):** These models learn a compressed representation (latent space) of molecules and can then decode points in this space to generate new molecular structures.\n    *   **Reinforcement Learning:** AI agents can learn to build molecules step-by-step, receiving rewards for creating molecules that meet specific criteria.\n    *   **Large Language Models (LLMs) for Chemistry:** While LLMs are known for text, they are being adapted to \"understand\" and generate molecular structures represented as sequences (like SMILES strings). This allows them to leverage vast amounts of chemical literature and data.\n\n**What it Means for Drug Discovery:**\n\n*   **Vastly Expanded Chemical Space:** AI can explore regions of chemical space that were previously inaccessible or unconsidered, leading to entirely new classes of drugs.\n*   **Faster Design Cycles:** Generating novel molecules can be much faster than traditional synthesis and screening methods.\n*   **Tailored Solutions:** Molecules can be designed with specific therapeutic profiles in mind from the outset, potentially leading to more effective and safer drugs.\n*   **Addressing \"Undruggable\" Targets:** AI's ability to design novel scaffolds might help in developing drugs for targets that were previously considered too difficult to drug.\n*   **Reduced Costs:** By making the design process more efficient and reducing the number of failed candidates, AI can potentially lower the overall cost of drug development.\n\n**Examples and Impact:**\n\nCompanies using this approach are reporting significant successes. For instance, they might design a molecule that has a unique binding mode to a cancer protein, or one that is predicted to have fewer side effects than existing treatments. These AI-designed molecules are then moving into laboratory synthesis and pre-clinical testing, with some already progressing into human clinical trials.\n\nThis development represents a significant leap forward, moving from \"finding\" drugs to \"inventing\" them, and it's a major driver of the excitement around AI in the pharmaceutical industry.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  The landscape of companies involved in AI-driven novel molecule design and optimization is rapidly evolving, with a mix of established pharmaceutical giants, dedicated AI drug discovery startups, and even tech companies venturing into the space.\n\nHere are some of the key players and categories of companies:\n\n**1. Dedicated AI Drug Discovery Companies (Startups & Scale-ups):**\n\nThese companies are founded with AI at their core and are often pioneers in generative AI for drug design.\n\n*   **Insilico Medicine:** A prominent player known for its end-to-end AI platform that designs molecules from target identification to clinical candidate selection. They have several AI-discovered drugs in clinical trials.\n*   **Exscientia:** Another leader that uses AI to design novel molecules and optimize them for preclinical and clinical development. They've established numerous partnerships with larger pharma companies.\n*   **Atomwise:** Focuses on using deep learning for small molecule drug discovery, particularly for screening and predicting interactions. They have a strong focus on computational methods.\n*   **Recursion Pharmaceuticals:** While not solely focused on molecule design, Recursion uses AI and machine learning to analyze biological data (images of cells) to discover new drug targets and potential therapies. Their platform can lead to novel molecule identification.\n*   **SchrÃ¶dinger:** A well-established computational chemistry company that has heavily integrated AI into its platform for molecular design, property prediction, and optimization.\n*   **BenevolentAI:** Uses AI to mine vast amounts of biomedical data to identify drug targets and generate novel hypotheses, which then inform molecule design.\n*   **AbCellera:** While primarily focused on antibody discovery, their AI platform is also used to design and optimize therapeutic molecules.\n*   **Nurix Therapeutics:** Uses AI to design molecules that modulate protein degradation, a novel therapeutic modality.\n\n**2. Large Pharmaceutical Companies with In-House AI Capabilities and Partnerships:**\n\nMajor pharmaceutical companies are heavily investing in building their own AI capabilities and partnering with specialized AI companies.\n\n*   **Pfizer:** Has been actively integrating AI into its R&D, including molecule design and optimization, through internal teams and collaborations.\n*   **Novartis:** A leader in adopting computational and AI approaches, with significant investments in AI-driven drug discovery.\n*   **Roche (Genentech):** Employs AI for various stages of drug discovery, including designing and optimizing small molecules and biologics.\n*   **Merck:** Actively uses AI for target identification and molecule design, often partnering with AI startups.\n*   **AstraZeneca:** Has made significant strides in AI for drug discovery, including developing novel chemical entities.\n*   **Sanofi:** Investing in AI to accelerate drug discovery and development, including novel molecule generation.\n*   **Gilead Sciences:** Utilizing AI and machine learning to explore new therapeutic avenues and design potential drug candidates.\n\n**3. Tech Giants and Cloud Providers:**\n\nWhile not directly designing drugs themselves, these companies provide the foundational AI technologies, cloud infrastructure, and specialized tools that enable AI drug discovery.\n\n*   **Google (DeepMind/Isomorphic Labs):** DeepMind's AlphaFold revolutionized protein structure prediction, and their spin-off, Isomorphic Labs, is explicitly focused on using AI for drug discovery, including molecule design.\n*   **Microsoft:** Provides cloud computing power and AI tools that are essential for large-scale AI drug discovery efforts.\n*   **Amazon (AWS):** Offers cloud infrastructure and AI services that support drug discovery companies.\n\n**Key Trends in Company Involvement:**\n\n*   **Partnerships and Collaborations:** It's very common for large pharma to partner with specialized AI drug discovery companies to leverage their cutting-edge technology.\n*   **In-House Development:** Many big pharma companies are building substantial internal AI/ML teams.\n*   **Focus on End-to-End Platforms:** Companies are increasingly aiming to offer integrated AI platforms that cover the entire drug discovery pipeline, from target to clinical candidate.\n*   **Emergence of New Modalities:** AI is being applied not just to small molecules but also to biologics, peptides, and even cell and gene therapies.\n\nThe field is highly competitive and collaborative, with constant innovation driving new companies and partnerships. It's a dynamic space where scientific rigor, AI expertise, and substantial investment are all critical for success.\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\nâœ… SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\nâŒ No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:21:30.414294Z","iopub.execute_input":"2025-11-14T04:21:30.414654Z","iopub.status.idle":"2025-11-14T04:21:30.429651Z","shell.execute_reply.started":"2025-11-14T04:21:30.414626Z","shell.execute_reply":"2025-11-14T04:21:30.428494Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\nâœ… SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='e97bdbd5-d338-4777-99ba-5abed70ad09e' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763094025.012857, 'end_timestamp': 1763094032.697497, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user inquired about the latest news in AI in healthcare. The AI agent provided a comprehensive overview, categorizing developments into Diagnostics, Drug Discovery, Personalized Medicine, Operational Efficiency, and Patient Engagement. Key trends highlighted included the impact of Generative AI (LLMs), the need for Explainable AI (XAI), evolving regulatory landscapes, data privacy concerns, and ethical considerations. The agent also recommended sources for staying updated on this rapidly evolving field.\\n\\nSubsequently, the user asked for more details on AI in drug discovery. The AI agent elaborated on this specific area, emphasizing \"Novel Molecule Design and Optimization.\" The core concept explained was the use of Generative AI to design entirely new molecules from scratch, rather than just screening existing ones. The process involves AI learning chemical and biological rules to create tailored molecular structures with desired properties. Technologies like GANs, VAEs, reinforcement learning, and adapted LLMs were mentioned. The impact of this development includes exploring new chemical spaces, accelerating design cycles, creating tailored drugs, potentially addressing previously \"undruggable\" targets, and reducing costs. The agent also noted that companies are already reporting successes with AI-designed molecules entering clinical trials.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='c1bc44b8-c748-42ce-934b-b345017ba7cb' timestamp=1763094038.332263\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"# Define scope levels for state keys (following best practices)\nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"âœ… Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:23:08.887369Z","iopub.execute_input":"2025-11-14T04:23:08.887741Z","iopub.status.idle":"2025-11-14T04:23:08.897435Z","shell.execute_reply.started":"2025-11-14T04:23:08.887699Z","shell.execute_reply":"2025-11-14T04:23:08.895960Z"}},"outputs":[{"name":"stdout","text":"âœ… Tools created.\n","output_type":"stream"}],"execution_count":17},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"âœ… Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:23:26.459633Z","iopub.execute_input":"2025-11-14T04:23:26.459974Z","iopub.status.idle":"2025-11-14T04:23:26.468927Z","shell.execute_reply.started":"2025-11-14T04:23:26.459950Z","shell.execute_reply":"2025-11-14T04:23:26.467635Z"}},"outputs":[{"name":"stdout","text":"âœ… Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":18},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:23:43.046415Z","iopub.execute_input":"2025-11-14T04:23:43.046824Z","iopub.status.idle":"2025-11-14T04:23:46.039545Z","shell.execute_reply.started":"2025-11-14T04:23:43.046802Z","shell.execute_reply":"2025-11-14T04:23:46.038541Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing well, thank you for asking. I can't recall your name at the moment. Would you mind telling me what it is?\n\nUser > My name is Sam. I'm from Poland.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  It is a pleasure to meet you, Sam! I will remember that you are from Poland.\n\nUser > What is my name? Which country am I from?\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n","output_type":"stream"}],"execution_count":19},{"cell_type":"code","source":"session = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:24:16.877481Z","iopub.execute_input":"2025-11-14T04:24:16.877844Z","iopub.status.idle":"2025-11-14T04:24:16.886508Z","shell.execute_reply.started":"2025-11-14T04:24:16.877818Z","shell.execute_reply":"2025-11-14T04:24:16.885226Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":20},{"cell_type":"code","source":"# Start a completely new session - the agent won't know our name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:29:20.373684Z","iopub.execute_input":"2025-11-14T04:29:20.374101Z","iopub.status.idle":"2025-11-14T04:29:20.988424Z","shell.execute_reply.started":"2025-11-14T04:29:20.374076Z","shell.execute_reply":"2025-11-14T04:29:20.987173Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great. I'd love to tell you your name, but I don't have that information stored. What should I call you? \n\n","output_type":"stream"}],"execution_count":21},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:29:47.118462Z","iopub.execute_input":"2025-11-14T04:29:47.118850Z","iopub.status.idle":"2025-11-14T04:29:47.125668Z","shell.execute_reply.started":"2025-11-14T04:29:47.118823Z","shell.execute_reply":"2025-11-14T04:29:47.124587Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n","output_type":"stream"}],"execution_count":22},{"cell_type":"code","source":"# Clean up any existing database to start fresh (if Notebook is restarted)\nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"âœ… Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T04:31:12.160135Z","iopub.execute_input":"2025-11-14T04:31:12.160509Z","iopub.status.idle":"2025-11-14T04:31:12.166902Z","shell.execute_reply.started":"2025-11-14T04:31:12.160483Z","shell.execute_reply":"2025-11-14T04:31:12.165772Z"}},"outputs":[{"name":"stdout","text":"âœ… Cleaned up old database files\n","output_type":"stream"}],"execution_count":23}]}